U.S. Physical Therapy, Inc. (USPH) Downgraded to “Sell” at Zacks Investment Research


Zacks Investment Research lowered shares of U.S. Physical Therapy, Inc. (NYSE:USPH) from a hold rating to a sell rating in a research note published on Wednesday.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

USPH has been the subject of a number of other research reports. Jefferies Group LLC set a $63.00 price target on shares of U.S. Physical Therapy and gave the stock a hold rating in a report on Saturday, March 18th. Barrington Research downgraded shares of U.S. Physical Therapy from an outperform rating to a market perform rating in a report on Friday, March 17th.

U.S. Physical Therapy (NYSE:USPH) traded up 0.08% during mid-day trading on Wednesday, hitting $63.55. The company had a trading volume of 64,329 shares. The firm’s 50 day moving average is $67.77 and its 200 day moving average is $66.92. The company has a market capitalization of $795.71 million, a price-to-earnings ratio of 32.93 and a beta of 0.91. U.S. Physical Therapy has a 52 week low of $48.10 and a 52 week high of $78.00.

ILLEGAL ACTIVITY WARNING: “U.S. Physical Therapy, Inc. (USPH) Downgraded to “Sell” at Zacks Investment Research” was originally posted by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this story on another site, it was copied illegally and republished in violation of U.S. and international trademark & copyright legislation. The correct version of this story can be read at https://www.thecerbatgem.com/2017/04/19/u-s-physical-therapy-inc-usph-downgraded-by-zacks-investment-research-updated-updated.html.

The firm also recently declared a quarterly dividend, which will be paid on Friday, May 5th. Shareholders of record on Monday, April 17th will be given a $0.20 dividend. This represents a $0.80 annualized dividend and a yield of 1.26%. The ex-dividend date is Wednesday, April 12th. This is a boost from U.S. Physical Therapy’s previous quarterly dividend of $0.17. U.S. Physical Therapy’s dividend payout ratio (DPR) is currently 35.05%.

A number of institutional investors have recently modified their holdings of USPH. Cue Financial Group Inc. acquired a new position in shares of U.S. Physical Therapy during the third quarter valued at approximately $492,000. Albert D Mason Inc. boosted its stake in U.S. Physical Therapy by 78.7% in the third quarter. Albert D Mason Inc. now owns 54,588 shares of the company’s stock valued at $3,423,000 after buying an additional 24,044 shares during the period. Great West Life Assurance Co. Can boosted its stake in U.S. Physical Therapy by 2.6% in the third quarter. Great West Life Assurance Co. Can now owns 17,993 shares of the company’s stock valued at $1,127,000 after buying an additional 450 shares during the period. Capital Fund Management S.A. purchased a new stake in U.S. Physical Therapy during the third quarter valued at about $445,000. Finally, Wells Fargo & Company MN boosted its stake in U.S. Physical Therapy by 3.3% in the third quarter. Wells Fargo & Company MN now owns 45,464 shares of the company’s stock valued at $2,851,000 after buying an additional 1,438 shares during the period. 96.70% of the stock is owned by institutional investors.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Get a free copy of the Zacks research report on U.S. Physical Therapy (USPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Stock Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related stocks with our FREE daily email newsletter.



Source link

U.S. Physical Therapy, Inc. (USPH) Downgraded to Hold at Zacks Investment Research


U.S. Physical Therapy, Inc. (NYSE:USPH) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.

According to Zacks, “U.S. Physical Therapy, Inc. operates outpatient physical and occupational therapy clinics which provide post-operative care and treatment for a variety of orthopedic-related disorders and sports-related injuries. “

Several other equities analysts have also recently issued reports on the company. Jefferies Group LLC reissued a “hold” rating and set a $63.00 target price (up from $60.00) on shares of U.S. Physical Therapy in a research note on Monday, December 5th. JMP Securities reissued a “hold” rating on shares of U.S. Physical Therapy in a research note on Monday, November 7th. Finally, Barrington Research raised U.S. Physical Therapy from a “market perform” rating to an “outperform” rating and set a $61.00 target price on the stock in a research note on Friday, November 4th.

U.S. Physical Therapy (NYSE:USPH) opened at 70.00 on Thursday. The firm has a 50-day moving average of $70.34 and a 200-day moving average of $63.89. The company has a market cap of $876.47 million, a price-to-earnings ratio of 36.27 and a beta of 0.91. U.S. Physical Therapy has a 52 week low of $45.76 and a 52 week high of $73.05.

COPYRIGHT VIOLATION NOTICE: This report was posted by Sports Perspectives and is owned by of Sports Perspectives. If you are viewing this report on another domain, it was copied illegally and republished in violation of United States & international copyright law. The correct version of this report can be read at https://sportsperspectives.com/2017/02/02/u-s-physical-therapy-inc-usph-downgraded-to-hold-at-zacks-investment-research.html.

In other U.S. Physical Therapy news, CFO Lawrance W. Mcafee sold 2,000 shares of the business’s stock in a transaction on Thursday, November 10th. The stock was sold at an average price of $58.04, for a total value of $116,080.00. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, Director Edward L. Kuntz sold 2,500 shares of the business’s stock in a transaction on Friday, December 9th. The stock was sold at an average price of $68.40, for a total value of $171,000.00. The disclosure for this sale can be found here. Insiders have sold 10,547 shares of company stock worth $659,654 over the last 90 days. 4.30% of the stock is currently owned by corporate insiders.

A number of large investors have recently added to or reduced their stakes in the company. Schroder Investment Management Group increased its stake in U.S. Physical Therapy by 209.2% in the third quarter. Schroder Investment Management Group now owns 319,373 shares of the company’s stock valued at $20,024,000 after buying an additional 216,073 shares during the period. Neuberger Berman Group LLC increased its stake in U.S. Physical Therapy by 24.6% in the second quarter. Neuberger Berman Group LLC now owns 947,897 shares of the company’s stock valued at $57,073,000 after buying an additional 187,395 shares during the period. Aberdeen Asset Management PLC UK increased its stake in U.S. Physical Therapy by 65.3% in the second quarter. Aberdeen Asset Management PLC UK now owns 321,707 shares of the company’s stock valued at $19,370,000 after buying an additional 127,094 shares during the period. Weatherbie Capital LLC increased its stake in U.S. Physical Therapy by 376.8% in the second quarter. Weatherbie Capital LLC now owns 91,110 shares of the company’s stock valued at $5,486,000 after buying an additional 72,000 shares during the period. Finally, Russell Investments Group Ltd. bought a new stake in U.S. Physical Therapy during the fourth quarter valued at approximately $4,733,000. 97.44% of the stock is currently owned by institutional investors and hedge funds.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc, through its subsidiaries, operates outpatient physical therapy clinics that provide pre-and post-operative care, and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers and neurological-related injuries.

5 Day Chart for NYSE:USPH

Receive News & Ratings for U.S. Physical Therapy Inc. Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for U.S. Physical Therapy Inc. and related companies with MarketBeat.com’s FREE daily email newsletter.



Source link